FDA clears Pathwork test that better identifies type of tumor Aug. 7, 2008 By Omar Ford A test developed by Pathwork Diagnostics (Sunnyvale, California) that can help healthcare professionals determine what specific type of cancer cells are present in a malignant tumor has been cleared by the FDA. (Diagnostics & Imaging Week)Read More
Financings roundup: CleveX raises private $1.4 million; IDS secures data collection funds Aug. 7, 2008
RSS